# Alta Med Health Services Corporation

Health Center, CA
Page: https://astrelis.co/providers/health_center/751153  
This twin: https://astrelis.co/providers/health_center/751153.md  
CMS Certification Number (CCN): 751153  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2024)

- **Total patients (UDS) (FY2024):** 295,386. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2021):** -612.4%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 134. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 6.7%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2021):** $0.0M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2021):** -289.0%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### ALTAMED HEALTH SERVICES CORPORATION, CA

Match to this profile: matched by name (method: name and state).

- FY ending 2025-12-31 (audit year 2025): balance sheet foots only; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000425336
- FY ending 2024-12-31 (audit year 2024): balance sheet foots only; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000383655
- FY ending 2023-12-31 (audit year 2023): balance sheet foots only; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000057380

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 1,161,250,031 [derived, p.6] | 919,765,201 [derived, p.7] | 853,020,062 [derived, p.7] |
| patient receivables, net (Statement of financial position) | 157,004,260 [derived, p.6] | 154,375,141 [derived, p.7] | 108,771,050 [derived, p.7] |
| grants and other receivables (Statement of financial position) | 30,703,735 [derived, p.6] | 32,453,465 [derived, p.7] | 29,227,597 [derived, p.7] |
| other current assets (Statement of financial position) | 26,017,644 [derived, p.6] | 23,557,635 [derived, p.7] | 24,128,609 [derived, p.7] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 1,374,975,671 [extracted, p.6] | 1,130,151,442 [extracted, p.7] | 1,015,147,318 [extracted, p.7] |
| property and equipment, net (Statement of financial position) | 475,134,508 [derived, p.6] | 434,255,839 [derived, p.7] | 368,133,207 [derived, p.7] |
| other long-term assets (Statement of financial position) | 242,233,320 [derived, p.6] | 222,625,145 [derived, p.7] | 199,367,481 [derived, p.7] |
| TOTAL ASSETS (Statement of financial position) | 2,092,343,498 [extracted, p.6] | 1,787,032,426 [extracted, p.7] | 1,582,648,006 [extracted, p.7] |
| payables and accrued expenses (Statement of financial position) | 378,476,462 [derived, p.6] | 302,286,686 [derived, p.7] | 227,803,984 [derived, p.7] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 46,545,330 [derived, p.6] | 61,645,042 [derived, p.7] | 25,744,058 [derived, p.7] |
| other current liabilities (Statement of financial position) | 47,509,402 [derived, p.6] | 15,432,138 [derived, p.7] | 27,249,920 [derived, p.7] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 472,531,193 [extracted, p.6] | 379,363,866 [extracted, p.7] | 280,797,962 [extracted, p.7] |
| long-term debt and leases (Statement of financial position) | 226,064,930 [derived, p.6] | 238,576,220 [derived, p.7] | 240,836,825 [derived, p.7] |
| other long-term liabilities (Statement of financial position) | 64,871,641 [derived, p.6] | 33,240,965 [derived, p.7] | 24,156,141 [derived, p.7] |
| TOTAL LIABILITIES (Statement of financial position) | 763,467,764 [extracted, p.6] | 651,181,051 [extracted, p.7] | 545,790,928 [extracted, p.7] |
| net assets without donor restrictions (Statement of financial position) | 1,259,686,421 [derived, p.6] | 1,066,961,564 [derived, p.7] | 969,739,134 [derived, p.7] |
| net assets with donor restrictions (Statement of financial position) | 69,189,313 [derived, p.6] | 68,889,811 [derived, p.7] | 67,117,944 [derived, p.7] |
| TOTAL NET ASSETS (Statement of financial position) | 1,328,875,734 [extracted, p.6] | 1,135,851,375 [extracted, p.7] | 1,036,857,078 [extracted, p.7] |
| patient service revenue, net (Statement of activities) | 1,976,820,947 [derived, p.7] | 1,630,646,099 [derived, p.8] | 1,342,098,846 [derived, p.8] |
| pharmacy and 340B revenue (Statement of activities) | 166,730,083 [derived, p.7] | 123,427,954 [derived, p.8] | 99,154,440 [derived, p.8] |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 74,918,801 [derived, p.7] | 73,064,680 [derived, p.8] | 41,522,548 [derived, p.8] |
| contributions (Statement of activities) | 15,750,138 [derived, p.7] | 7,667,197 [derived, p.8] | 10,535,931 [derived, p.8] |
| other revenue (Statement of activities) | 28,040,564 [derived, p.7] | 19,111,547 [derived, p.8] | 39,462,443 [derived, p.8] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 2,262,260,532 [extracted, p.7] | 1,853,917,477 [extracted, p.8] | 1,532,774,208 [extracted, p.8] |
| salaries and benefits (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| supplies and pharmaceuticals (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| occupancy (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | 2,181,795,454 [derived, p.7] | 1,817,839,063 [derived, p.8] | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 2,181,795,454 [extracted, p.7] | 1,817,839,063 [extracted, p.8] | 1,437,483,828 [extracted, p.8] |
| OPERATING RESULT (Statement of activities) | 80,465,078 [extracted, p.7] | 36,078,414 [extracted, p.8] | 95,290,380 [extracted, p.8] |
| non-operating and other changes (Statement of activities) | -63,369,006 [derived, p.7] | 69,223,959 [derived, p.8] | 100,669,938 [derived, p.8] |
| CHANGE IN NET ASSETS (Statement of activities) | 193,024,359 [extracted, p.7] | 98,995,297 [extracted, p.8] | 178,353,106 [extracted, p.8] |
| net assets, beginning (Statement of activities) | 1,135,851,375 [extracted, p.7] | 1,036,856,078 [extracted, p.8] | 858,503,972 [extracted, p.8] |
| net assets, end (Statement of activities) | 1,328,875,734 [extracted, p.7] | 1,135,851,375 [extracted, p.8] | 1,036,857,078 [extracted, p.8] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | absent [not computed] | absent [not computed] | absent [not computed] |
| Current ratio | 2.91x [plausible] | 2.98x [plausible] | 3.62x [plausible] |
| Operating margin | 3.6% [plausible] | 1.9% [plausible] | 6.2% [plausible] |
| Total margin | 8.5% [plausible] | 5.3% [plausible] | 11.6% [plausible] |
| Patient revenue share | 87.4% [plausible] | 88.0% [plausible] | 87.6% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | absent [not computed] | absent [not computed] | absent [not computed] |
| Days in patient receivables | 29 days [plausible] | 35 days [plausible] | 30 days [plausible] |
| Debt to net assets | 0.21x [plausible] | 0.26x [plausible] | 0.26x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (ALTAMED HEALTH SERVICES CORPORATION; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Alta Med Health Services Corporation", https://astrelis.co/providers/health_center/751153, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.
